# Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia

> **NCT02203838** · PHASE3 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 500 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** RBP-7000

## Key facts

- **NCT ID:** NCT02203838
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2018-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02203838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02203838, "Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02203838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*